<--- Back to Details
First PageDocument Content
Pharmacology / Bristol-Myers Squibb / Cetuximab / Panitumumab / KRAS / Bevacizumab / Colorectal cancer / FOLFIRI / Epidermal growth factor receptor / Medicine / Chemistry / Chemotherapy regimens
Date: 2014-10-01 21:56:23
Pharmacology
Bristol-Myers Squibb
Cetuximab
Panitumumab
KRAS
Bevacizumab
Colorectal cancer
FOLFIRI
Epidermal growth factor receptor
Medicine
Chemistry
Chemotherapy regimens

Microsoft WordPanitumumab Amgen PSD March 2013 FINAL .docx

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 55,80 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document